Liraglutide in Newly Onset Type 1 Diabetes.

NCT01879917 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Liraglutide
DRUG: Placebo

Sponsor

Hvidovre University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]